http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1686360-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8e85813dd65d8108835caaecfee8e8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc2c2b8e15a85579d38968ab0fc7d933
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff61011f049e9f9a14494746d3df7ad7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0f6adb811edeab02211ac9873f2f74c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_603c6e11e5e3faef02c461d9771de5fc
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49
filingDate 1988-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1991-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37fd369474f243fcf76e0a978ce2b2cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_878ff0bfe92b66e20f97b59eaf207fa9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ba824f43f00f0259bbc1920dc62ce16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c2afd11d7bb4856add6ba1af5ed66b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4974f15554ac88e149185aea8cecb258
publicationDate 1991-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SU-1686360-A1
titleOfInvention Method for prognostication of untoward postoperative course in surgical treatment of portal hypertensive disease
abstract The invention relates to the field of medicine, namely to methods for predicting the postoperative period in patients with portal hypertension. The aim of the invention is to improve the accuracy of the forecast. For this, in the preoperative period, 9 ml of blood is taken from the ulnar vein and diluted in a 9: 1 ratio with a 3.8% sodium citrate solution. Blood is defended for 1.5 hours, platelet-rich plasma is taken from above. The platelet content is adjusted to 300 109 / l by diluting with platelet-free plasma obtained from the same blood. 3 10 m ADP is added to the platelet sample according to the aggregation curve recorded on the aggregator. When the disaggregation rate is equal to 7.0 U, ext / min or less, an adverse postoperative period is predicted. The forecast accuracy is 93.9%. The method allows the correct choice of treatment tactics and postoperative benefit in treating portal hypertension in patients with liver cirrhosis with portal hypertension syndrome and thereby increasing the effectiveness of treatment. (Ls
priorityDate 1988-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349

Total number of triples: 23.